Nuix (NXL) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
23 Feb, 2026Executive summary
ACV grew 8.4% year-over-year to $234.4 million, with Neo ACV surging 148% to $46.8 million and now representing 20% of total ACV.
Revenue increased 15.2% year-over-year to $121.2 million, driving adjusted management EBITDA up 42.6% to $19.1 million and statutory EBITDA up 72.7% to $26.5 million.
Positive underlying and overall cash flow achieved, with a closing cash balance of $57.8 million, up 88.4% year-over-year.
Launch of a comprehensive Neo migration program to accelerate customer transition and drive further ACV growth.
Acquisition of Linkurious for up to €20 million to enhance graph technology and data visualisation, pending regulatory approval.
Financial highlights
Adjusted management EBITDA margin expanded from 12.7% to 15.8%.
Net dollar retention declined to 101% from 109.6% year-over-year, mainly due to downsell in large clients and project completions.
Free cash flow conversion ratio reached 149%, with underlying cash flow of $28.4 million and free cash flow of $20.4 million.
Multi-year deals accounted for 33% of revenue, up from 22% in the prior period.
R&D spend was $28.8 million, representing 24% of revenue, with 43% capitalised.
Outlook and guidance
ACV guidance for FY26 is reaffirmed at $240 million–$260 million, excluding any ACV from the Linkurious acquisition.
ACV is expected to be weighted to the second half, consistent with renewal cycles.
Focus remains on business transformation, Neo-driven ACV growth, revenue growth outpacing operating costs, and maintaining positive cash flows.
Strategic focus on expanding Neo capabilities and migrating customers to the Neo platform.
The Linkurious acquisition is expected to close in Q1 2026, enhancing AI and graph analytics capabilities.
Latest events from Nuix
- Double-digit growth in ACV, revenue, and EBITDA, with new platform driving momentum.NXL
H2 202423 Jan 2026 - Robust FY24 results and AI-driven innovation set the stage for further growth.NXL
AGM 202414 Jan 2026 - ACV up 8.3% and revenue up 6.9%, with strong Neo momentum and positive cash flow despite higher losses.NXL
H1 202523 Dec 2025 - ACV up 8% to AUD 228.4m, Nuix Neo ACV up 132%, and cash EBITDA up 24.5% year-over-year.NXL
H2 202523 Nov 2025 - AI-driven innovation and rapid processing power set new standards for data solutions.NXL
Investor Day 2025 Presentation22 Sep 2025